Eventually, the microbiome likely affects the pathophysiology of cGvHD; bacterial strains in addition to microbial metabolites could display prospective biomarkers for dysbiosis and risk for the development of cGvHD. In summary, though there are no validated biomarkers available for clinical use to raised inform on the analysis, prognosis or…[Read more]